Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Oncological Patients with Endocrine Complications after Immunotherapy with Checkpoint Inhibitors Present Longer Progression Free and Overall Survival — Stavroula Α. Paschou (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Oncological Patients with Endocrine Complications after Immunotherapy with Checkpoint Inhibitors Present Longer Progression Free and Overall Survival
Shared by
Meletios A Dimopoulos
Oncological Patients with Endocrine Complications after Immunotherapy with Checkpoint Inhibitors Present Longer Progression Free and Overall Survival
Article
2021
en
Authors
+6 more
SP
Stavroula Α. Paschou
ML
Michalis Liontos
EE
Evangelos Eleftherakis-Papaiakovou
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
Oncological patients with endocrine complications after immunotherapy with checkpoint inhibitors present longer progression free and overall survival
Stavroula Α. Paschou
,
Michalis Liontos
,
Evangelos Eleftherakis-Papaiakovou
,
Katerina Stefanaki
,
Christos Markellos
,
Konstantinos Koutsoukos
,
Flora Zagouri
,
Θεοδώρα Ψαλτοπούλου
,
Meletios A Dimopoulos
Article
2022
Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival
Stavroula Α. Paschou
,
Michalis Liontos
,
Evangelos Eleftherakis-Papaiakovou
,
Katerina Stefanaki
,
Christos Markellos
,
Konstantinos Koutsoukos
,
Flora Zagouri
,
Θεοδώρα Ψαλτοπούλου
,
Meletios A Dimopoulos
Article
2021
How we treat endocrine complications of immune checkpoint inhibitors
Stavroula Α. Paschou
,
Katerina Stefanaki
,
Θεοδώρα Ψαλτοπούλου
,
Michalis Liontos
,
Konstantinos Koutsoukos
,
Flora Zagouri
,
Ιrene Lambrinoudaki
,
Meletios A Dimopoulos
Article
2024
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
Meletios A Dimopoulos
,
Pieter Sonneveld
,
Salomon Manier
,
Annette Lam
,
Tito Roccia
,
Jordan M. Schecter
,
Patricia Cost
,
Lida Pacaud
,
Abbey E. Poirier
,
Gabriel Tremblay
,
Tommy Lan
,
Satish Valluri
,
Shaji Kumar
Article
2017
Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Patients with Relapsed or Refractory Multiple Myeloma
Meletios A Dimopoulos
,
Pieter Sonneveld
,
Hareth Nahi
,
Shaji Kumar
,
Mahmoud Hashim
,
Margarita Kulakova
,
Marta Duran
,
Bart Heeg
,
Annette Lam
,
Lindsay Dearden
Discussion(0)
No comments yet. Be the first to comment.